Press Releases

Gummy Market Size to Worth Around USD 52.06 Bn by 2030

Share This Article

The global Gummy market is expected to grow at a CAGR of around zz% over the forecast period 2021 to 2030 and expected to reach the market value of around US$ 52.06 billion by 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38447

Growth Factors

The advent of organic, clean, and natural formulated gummy supplements by key market participants; coupled with increasing customer demand for nutrition with taste and flavor is a major factor fueling the market growth.

Gummies are easy to chew and can be consumed on the go, thereby providing an easy supplementation solution during busy working schedules for adult consumers. Besides, gummies are highly popular among kids due to the availability of different flavors, colors, and attractive shapes.

Moreover, the prevailing trend of adopting preventive healthcare measures by parents since the birth of a baby is expected to drive the growth of the market in the coming years. In addition, the busy lifestyle of individuals has encouraged on-the-go eating habits; thus, a shifting focus towards an alternative form of nutrients which is expected to stimulate growth for convenient and easy-to-swallow gummy. 

Report Highlights

 The vitamins segment led the market accounting for more than 65% of the overall revenue share in 2020. The increasing working-class population and changes in lifestyles have failed to keep up with the nutrition requirement through food; thus, the demand for vitamin supplements has been increasing.

Factors fueling interest in vitamin supplements also include increasing healthcare costs, a growing aging population, and rising awareness about maintaining a healthy diet. Moreo0ver, gummies are a convenient vitamin delivery system for children, who are reluctant to consume supplements in other forms.

The adult end-user segment dominated the market with a revenue share of more than 72% in 2020. The rising demand for convenient dietary supplements from working professionals, sports enthusiasts, elderly people, and pregnant women is expected to augment the growth of the adult end-user segment over the forecast period.

The trend of clean labels and organic products has shifted consumer preference toward botanicals. Consumers are willing to pay more for supplements with such health claims owing to their anti-inflammatory and anticancer properties.

The non-store distribution channel segment is expected to witness the fastest CAGR of more than 24% during the forecast period. Increasingly sophisticated consumer demands coupled with the rising penetration of e-commerce are mainly driving the growth of this segment. Key manufacturers are accessing new distribution channels to connect with the diverse consumer base, which has increased the product sales through the non-store-based channels, such as online stores and other e-retailers like Amazon, 1mg, and others.

North America dominated the market and accounted for a revenue share of over 48% in 2020. Over the past decade, the dietary supplement industry has witnessed significant growth in North America with the expansion of a health-conscious consumer base, particularly in developed countries, such as the U.S. and Canada.

Key Players

  • Procaps Group
  • Santa Cruz Nutritionals
  • Amapharm
  • Herbaland Canada
  • Allseps Pty. Ltd.
  • Vitux AS
  • Boscogen, Inc.
  • Bettera Brands, LLC
  • NutraStar Manufacturing Ltd.
  • Better Nutritionals
  • Prime Health Ltd.
  • AJES Pharmaceuticals LLC
  • Lactonova
  • SMPNutra.com
  • Lexicare Pharma Pvt. Ltd.
  • Superior Supplement Manufacturing
  • Well Aliments
  • Supplement Factory Ltd.
  • Vitakem Nutraceutical, Inc.
Report Coverage Details
Market Size US$ 52.06 billion by 2030
Growth Rate CAGR of 16.8% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Application, End user, Distribution Channel
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Procaps Group; Santa Cruz Nutritionals; Amapharm; Herbaland Canada; Allseps Pty. Ltd.; Vitux AS; Boscogen, Inc.; Bettera Brands, LLC; NutraStar Manufacturing Ltd.; Better Nutritionals; Prime Health Ltd.; AJES Pharmaceuticals LLC; Lactonova; SMPNutra.com; Lexicare Pharma Pvt. Ltd.; Superior Supplement Manufacturing; Well Aliments; Supplement Factory Ltd.; Vitakem Nutraceutical, Inc.

Market Segmentation

  • Application
    • Vitamins
    • Minerals
    • Omega Fatty Acids
    • Proteins
    • Others (Probiotics, Botanicals, Fibers)
  • End User
    • Adult
    • Kids
  • Distribution Channel
    • Store-based
    • Non-store-based
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
    • Central & South America
      • Brazil
      • Columbia
    • Middle East & Africa
      • South Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38447

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Gummy Market, By Application

7.1.  Gummy Market, by Application, 2021-2030

7.1.1.    Vitamins

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Minerals

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Omega Fatty Acids

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Proteins

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Others (Probiotics, Botanicals, Fibers)

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Gummy Market, By End User

8.1.  Gummy Market, by End User, 2021-2030

8.1.1.    Adult

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Kids

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Gummy Market, By Distribution Channel

9.1.  Gummy Market, by Distribution Channel, 2021-2030

9.1.1.    Store-based

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Non-store-based

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Gummy Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Application (2016-2030)

10.1.2.  Market Revenue and Forecast, by End User (2016-2030)

10.1.3.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by End User (2016-2030)

10.1.4.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by End User (2016-2030)

10.1.5.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Application (2016-2030)

10.2.2.  Market Revenue and Forecast, by End User (2016-2030)

10.2.3.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by End User (2016-2030)

10.2.4.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by End User (2016-2030)

10.2.5.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by End User (2016-2030)

10.2.6.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Application (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by End User (2016-2030)

10.2.7.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Application (2016-2030)

10.3.2.  Market Revenue and Forecast, by End User (2016-2030)

10.3.3.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by End User (2016-2030)

10.3.4.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by End User (2016-2030)

10.3.5.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by End User (2016-2030)

10.3.6.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Application (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by End User (2016-2030)

10.3.7.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Application (2016-2030)

10.4.2.  Market Revenue and Forecast, by End User (2016-2030)

10.4.3.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by End User (2016-2030)

10.4.4.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by End User (2016-2030)

10.4.5.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by End User (2016-2030)

10.4.6.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Application (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by End User (2016-2030)

10.4.7.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Application (2016-2030)

10.5.2.  Market Revenue and Forecast, by End User (2016-2030)

10.5.3.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Application (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by End User (2016-2030)

10.5.4.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Application (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by End User (2016-2030)

10.5.5.3.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

Chapter 11.  Company Profiles

11.1.              Procaps Group

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Santa Cruz Nutritionals

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Amapharm

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Herbaland Canada

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Allseps Pty. Ltd.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Vitux AS

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Boscogen, Inc.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Bettera Brands, LLC

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              NutraStar Manufacturing Ltd.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Better Nutritionals

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           Prime Health Ltd.

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

11.12.           AJES Pharmaceuticals LLC

11.12.1.               Company Overview

11.12.2.               Product Offerings

11.12.3.               Financial Performance

11.12.4.               Recent Initiatives

11.13.           Lactonova

11.13.1.               Company Overview

11.13.2.               Product Offerings

11.13.3.               Financial Performance

11.13.4.               Recent Initiatives

11.14.           SMPNutra.com

11.14.1.               Company Overview

11.14.2.               Product Offerings

11.14.3.               Financial Performance

11.14.4.               Recent Initiatives

11.15.           Lexicare Pharma Pvt. Ltd.

11.15.1.               Company Overview

11.15.2.               Product Offerings

11.15.3.               Financial Performance

11.15.4.               Recent Initiatives

11.16.           Superior Supplement Manufacturing

11.16.1.               Company Overview

11.16.2.               Product Offerings

11.16.3.               Financial Performance

11.16.4.               Recent Initiatives

11.17.           Well Aliments

11.17.1.               Company Overview

11.17.2.               Product Offerings

11.17.3.               Financial Performance

11.17.4.               Recent Initiatives

11.18.           Supplement Factory Ltd.

11.18.1.               Company Overview

11.18.2.               Product Offerings

11.18.3.               Financial Performance

11.18.4.               Recent Initiatives

11.19.           Vitakem Nutraceutical, Inc.

11.19.1.               Company Overview

11.19.2.               Product Offerings

11.19.3.               Financial Performance

11.19.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38447

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button